DCF — WAKE MED CARY HOSPITAL
Enterprise Value: $-221.3M
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$-221.3M
Enterprise Value
$-76.4M
PV of Cash Flows
$-144.9M
PV of Terminal Value
$-233.4M
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $327.7M | $-10.3M | -3.0% | $-24.2M | $-22.0M |
| Year 2 | $337.5M | $-7.2M | -2.0% | $-21.5M | $-17.8M |
| Year 3 | $347.6M | $-4.0M | -1.0% | $-18.7M | $-14.1M |
| Year 4 | $358.1M | $-2.3M | -1.0% | $-17.5M | $-11.9M |
| Year 5 | $368.8M | $-1.5M | -0.0% | $-17.1M | $-10.6M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $-221.3M. Terminal value accounts for 0% of total EV — consider sensitivity to terminal assumptions.
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$318.1M
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base-0.03647653119511581
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5